CMS certification 150162
Franciscan Health Indianapolis
8111 S Emerson Ave, Indianapolis, IN 46237
Franciscan Health Indianapolis has a CMS overall rating of 4 out of 5 stars. 77% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 3. Emergency patients spend a median of 3 h 32 min in its emergency department before leaving (US median 2 h 42 min).
Every figure on this page is published by CMS; we arrange and explain it, and score nothing ourselves.
What patients said
Answers from patients who stayed here, collected by CMS in the national HCAHPS survey: 478 completed surveys, 25% response rate, Oct 2024 – Sep 2025.
Emergency department
How long emergency patients spent here and how some time-critical care went, from CMS's timely and effective care measures, Oct 2024 – Sep 2025. CMS classes this emergency department's patient volume as very high; busier departments tend to have longer times, so the national median for departments of the same volume is shown too. These are medians over a year of visits, not a live wait time.
| Measure | This hospital | IN | US |
|---|---|---|---|
| Median time in the emergency department before leaving Lower is better · 393 visits sampled · US median for EDs of the same volume: 3 h 21 min | 3 h 32 min | 2 h 25 min | 2 h 42 min |
| Median time for psychiatric and mental health patients Lower is better · 18 visits sampled | 7 h 12 min | 3 h 51 min | 4 h 17 min |
| Left before being seen Lower is better · 65,516 patients | 2% | 2% | 2% |
| Stroke symptoms: brain scan read within 45 minutes Higher is better · 17 patients | 76% | 71% | 69% |
| Severe sepsis and septic shock: all recommended care given Higher is better · 188 patients | 52% | 60% | 65% |
How Franciscan Health Indianapolis compares with nearby hospitals
The closest hospitals of the same kind that CMS rates or surveys - the same city first, then the same county and ZIP area. Every figure is CMS's: the overall star rating, the share of patients who would definitely recommend the hospital, the median time emergency patients spent before leaving, and how many death, complication, infection and readmission measures CMS found better or worse than the national rate.
| Hospital | CMS stars | Would recommend | ER median time | Vs the nation |
|---|---|---|---|---|
| Franciscan Health IndianapolisThis hospital | 4/5 | 77% | 3 h 32 min | 2 better 3 worse |
| Community Hospital South, INC.Same city | 3/5 | 79% | 3 h 16 min | 1 better 3 worse |
| Community Hospital EastSame city | 3/5 | 79% | 2 h 50 min | 2 better 4 worse |
| Community Hospital NorthSame city | 3/5 | 72% | 3 h 41 min | 4 better 1 worse |
| Ascension St Vincent HospitalSame city | 2/5 | 61% | 2 h 5 min | 3 better 3 worse |
| Eskenazi HealthSame city | 3/5 | 76% | 3 h 52 min | 2 better 1 worse |
Hospitals differ in size and in how sick their patients are. CMS adjusts its outcome measures for that, but a star or a percentage is a starting point for questions, not a verdict. All hospitals in Indianapolis.
Deaths
How many patients died within 30 days of admission, adjusted by CMS for how sick they were. Lower is better. Data from Jul 2022 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| All patients, hospital-wide 5,165 cases | Too few cases | 3% | 3.9% |
| Heart attack 281 cases | Too few cases | 11.3% | 11.9% |
| Heart failure 627 cases | Too few cases | 9.5% | 11.1% |
| Pneumonia 1,014 cases | Too few cases | 15.1% | 15.2% |
| Stroke 590 cases | Too few cases | 7% | 11.9% |
| COPD 135 cases | Too few cases | 8.1% | 8.6% |
| Heart bypass surgery (CABG) 129 cases | Too few cases | 3.2% | 2.4% |
Complications
How often patients had serious complications, most of them after surgery, adjusted for how sick they were. Lower is better. Data from Jul 2022 – Jun 2024.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Serious complications, combined measure | No different | 0.87 likely 0.63 – 1.12 | 1 |
| Deaths after a serious but treatable surgical complication 190 cases | No different | 188.65 per 1,000 likely 148.5 per 1,000 – 228.8 per 1,000 | 173.3 per 1,000 |
| Pressure ulcers (bed sores) 8,002 cases | No different | 0.23 per 1,000 likely 0 per 1,000 – 0.78 per 1,000 | 0.63 per 1,000 |
| Collapsed lung caused by a procedure 10,451 cases | No different | 0.25 per 1,000 likely 0.07 per 1,000 – 0.43 per 1,000 | 0.21 per 1,000 |
| Broken bones from falls in the hospital 11,010 cases | No different | 0.34 per 1,000 likely 0.16 per 1,000 – 0.52 per 1,000 | 0.27 per 1,000 |
| Bleeding or hematoma after surgery 2,475 cases | No different | 1.6 per 1,000 likely 0.33 per 1,000 – 2.87 per 1,000 | 2.34 per 1,000 |
| Kidney injury needing dialysis after surgery 1,078 cases | No different | 2.08 per 1,000 likely 0.84 per 1,000 – 3.32 per 1,000 | 1.67 per 1,000 |
| Breathing failure after surgery 1,079 cases | No different | 8.11 per 1,000 likely 4.11 per 1,000 – 12.1 per 1,000 | 9.42 per 1,000 |
| Blood clots in the lungs or legs after surgery 2,631 cases | No different | 3.86 per 1,000 likely 2.1 per 1,000 – 5.62 per 1,000 | 3.52 per 1,000 |
| Sepsis after surgery 1,052 cases | No different | 5.18 per 1,000 likely 2.32 per 1,000 – 8.03 per 1,000 | 5.27 per 1,000 |
| Surgical wound splitting open 618 cases | No different | 1.52 per 1,000 likely 0.1 per 1,000 – 2.94 per 1,000 | 1.77 per 1,000 |
| Accidental cut or tear during abdominal surgery 2,179 cases | No different | 0.77 per 1,000 likely 0 per 1,000 – 1.59 per 1,000 | 1.06 per 1,000 |
1 more measure had too few cases here to report.
Infections caught in the hospital
Standardized infection ratio: 1.0 means as many infections as CMS predicted for a hospital like this one. Lower is better. Data from Oct 2024 – Sep 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Bloodstream infections from central lines (CLABSI) | Better | 0.42 likely 0.16 – 0.94 | 1 |
| Urinary tract infections from catheters (CAUTI) | No different | 0.79 likely 0.42 – 1.37 | 1 |
| Surgical site infections after colon surgery | No different | 1.03 likely 0.52 – 1.83 | 1 |
| Surgical site infections after abdominal hysterectomy | No different | 1.23 likely 0.21 – 4.07 | 1 |
| MRSA bloodstream infections | No different | 0.5 likely 0.16 – 1.21 | 1 |
| C. diff intestinal infections | Better | 0.66 likely 0.52 – 0.82 | 1 |
Readmissions and return visits
How often patients had to come back to a hospital after going home. Lower is better. Data from Jul 2023 – Jun 2025.
| Measure | CMS comparison | This hospital | National |
|---|---|---|---|
| Readmitted after a heart attack 498 cases | Too few cases | 14% | 14.4% |
| Readmitted after heart failure 979 cases | Too few cases | 19.4% | 21.3% |
| Readmitted after pneumonia 1,713 cases | Too few cases | 19.2% | 17.3% |
| Readmitted after COPD 291 cases | Too few cases | 19.6% | 20% |
| Readmitted after heart bypass surgery 167 cases | Too few cases | 9.8% | 11% |
| Days back in hospital after a heart attack 313 cases | Too few cases | -0.9 days per 100 | — |
| Days back in hospital after heart failure 720 cases | Too few cases | -36.5 days per 100 | — |
| Days back in hospital after pneumonia 1,097 cases | Too few cases | 25.6 days per 100 | — |
| Unplanned visits after an outpatient colonoscopy 509 cases | No different | 11.7 per 1,000 likely 8.9 per 1,000 – 15.5 per 1,000 | 13 per 1,000 |
| Hospital admissions during outpatient chemotherapy 337 cases | No different | 11.4 per 100 likely 9 per 100 – 14.3 per 100 | 10.7 per 100 |
| ER visits during outpatient chemotherapy 337 cases | No different | 4.9 per 100 likely 3.5 per 100 – 6.7 per 100 | 5.4 per 100 |
| Unplanned visits after outpatient surgery 407 cases | No different | 1.2 likely 0.9 – 1.5 | — |
2 more measures had too few cases here to report.
Clinicians registered at this address
222 clinicians give this hospital's street address as their practice location in NPPES, the federal provider registry. The same address can take in offices and clinics in the building, and a listing does not prove admitting privileges or current employment.
| Specialty | Clinicians |
|---|---|
| Anesthesiology | 28 |
| Emergency Medicine | 26 |
| Physician Assistant | 23 |
| Family | 15 |
| Physical Therapist | 11 |
| Pharmacist | 10 |
| Hematology & Oncology | 9 |
| Neonatal | 9 |
| Dietitian, Registered | 7 |
| Adult Health | 6 |
| Gerontology | 5 |
| Nurse Practitioner | 5 |
First 12 alphabetically
Money from drug and device companies
Drug and device makers have to report what they pay teaching hospitals to CMS's Open Payments program. At many teaching hospitals most of it is research funding, or royalties for inventions the hospital licensed to a company. A payment on its own does not show a conflict of interest.
- 2019 $458,580
- 2020 $259,561
- 2021 $286,354
- 2022 $521,579
- 2023 $0
- 2024 $595,583
- 2025 $795,054
What the 2025 general payments were for
| Type of payment | Amount | Payments |
|---|---|---|
| Medical devices and supplies on long-term loan | $7,497 | 1 |
| Debt forgiveness | $5,885 | 15 |
Largest paying companies, 2025
| Company | Amount | Payments |
|---|---|---|
| Novartis Pharmaceuticals Corporation | $447,353 | 6 |
| Amgen Inc. | $251,846 | 3 |
| Merck Sharp & Dohme LLC | $51,630 | 3 |
| AtriCure, Inc. | $12,569 | 8 |
| Cleerly, Inc. | $8,012 | 4 |
| LeMaitre Vascular, Inc. | $7,497 | 1 |
| Bioventus LLC | $5,447 | 14 |
| Artivion, Inc. | $4,835 | 2 |
Largest research studies funded here, 2025
| Study | Amount |
|---|---|
| A Phase II Multicenter, Open-label, Single-arm Dose Escalation Study of Asciminib Monotherapy in 2nd Line Chronic Phase - Chronic Myelogenous Leukemia Novartis Pharmaceuticals Corporation | $405,767 |
| Expanded Access use of IMDELLTRA to treat your patient with DLL3+ large cell neuroendocrine carcinoma of the lung Amgen Inc. | $183,315 |
| A Phase 3, Open-label, Multicenter, Randomized Study of Tarlatamab in Combination With Durvalumab vs Durvalumab Alone in Subjects With Extensive-Stag… Amgen Inc. | $47,024 |
| A Phase 3, Randomized, Double-blind, Active-Control Study of Pelabresib (CPI 0610) and Ruxolitinib vs. Placebo and Ruxolitinib in JAKi Treatment Naiv… Novartis Pharmaceuticals Corporation | $41,586 |
| A Phase 3, Randomized, Open-label Study to Evaluate the Efficacy and Safety of sac-TMT Sacituzumab Tirumotecan, MK-2870 Followed by Carboplatin,Pacli… Merck Sharp & Dohme LLC | $34,359 |
| A Double-blind, Randomized, Placebo-controlled, Multicenter Study Assessing Olpasiran Use to Prevent First Major Cardiovascular Events in Participant… Amgen Inc. | $21,507 |
| A Pivotal Phase 3 Randomized, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of the sGC Stimulator Vericiguat,MK-1242 in Adult… Merck Sharp & Dohme LLC | $17,270 |
| A MULTICENTER PATIENT REGISTRY FOR OUTCOMES FROM COMPREHENSIVE ABLATION TREATMENTS OF ATRIAL ARRHYTHMIAS AtriCure, Inc. · NCT05111015 | $11,000 |
Amounts are as the paying companies reported them to CMS; Open Payments data retrieved 13 Sep 2026. Full record on CMS Open Payments.
How to read this page
- Everything here is published by CMS on Care Compare. We arrange it and explain it; the star ratings and the better / worse verdicts are CMS's, not ours.
- “No different” is the most common result on most measures at most hospitals. CMS only calls a result better or worse when the difference from the national rate is statistically clear.
- Death, complication and readmission rates are adjusted by CMS for how sick patients were, so hospitals that treat sicker patients can be compared fairly.
- Infection results are ratios: 1.0 means as many infections as CMS predicted for a hospital like this one, below 1.0 is fewer.
- These are hospital-wide results. They do not rate an individual doctor, nurse or department, and they are not medical advice.
CMS Care Compare data retrieved 4 Oct 2026, refreshed weekly. Where this data comes from and how we handle it · Report an error
Common questions about Franciscan Health Indianapolis
Is Franciscan Health Indianapolis a good hospital?
Franciscan Health Indianapolis has a CMS overall rating of 4 out of 5 stars. Of the 25 death, complication, infection and readmission measures CMS could compare, it does better than the nation on 2 and worse on 3. These are hospital-wide results published by CMS; they do not rate individual doctors or departments.
Would patients recommend Franciscan Health Indianapolis?
77% of patients who answered CMS's national survey would definitely recommend it, against a US average of 71%. The figure comes from 478 completed HCAHPS surveys.
How long is the wait in the Franciscan Health Indianapolis emergency room?
Emergency patients spend a median of 3 h 32 min in its emergency department before leaving (US median 2 h 42 min). Among US emergency departments with very high patient volume, like this one, the median is 3 h 21 min. 2% of emergency patients left before being seen (US 2%). These are medians over a year of visits, not a live wait time.
Does Franciscan Health Indianapolis receive money from drug and device companies?
Drug and device makers reported $795,054 in payments to Franciscan Health Indianapolis for 2025, most of it research funding, under the federal Open Payments program. A payment on its own does not show a conflict of interest.